Home > slashdot > Super Strength Substance Approaching Human Trials

Super Strength Substance Approaching Human Trials

December 8th, 2009 12:55 admin Leave a comment Go to comments

kkleiner writes “You may remember Liam Hoekstra, the baby apparently born without the myostatin gene, and consequently sporting 40% more skeletal muscle than his peers. Using gene therapy, NCH scientists have been able to get follistatin (a myostatin blocker) to promote phenomenal muscle growth in macaque monkeys. NCH is now working with the FDA to perform the preliminary steps necessary for a human clinical trial. Is this the prelude to a super-strength gene therapy for all of us?”

Source: Super Strength Substance Approaching Human Trials

Related Articles:

  1. Human Clinical Trials To Begin On Drug That Reverses Diabetes In Animal Models
  2. HIV Vaccine Approval For Human Trials
  3. Device Allows Paralyzed Rats To Walk, Human Trials Scheduled Next Summer
  4. HIV Vaccine Safe Enough To Pass Phase 1 Human Trials
  5. Robotic Suit Gives Shipyard Workers Super Strength
blog comments powered by Disqus
YOYOYOOYOYOYO